X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3205) 3205
Publication (215) 215
Book Chapter (73) 73
Book Review (68) 68
Book / eBook (7) 7
Conference Proceeding (6) 6
Magazine Article (3) 3
Data Set (1) 1
Dissertation (1) 1
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1406) 1406
index medicus (1366) 1366
male (903) 903
animals (853) 853
female (748) 748
oncology (644) 644
reduced glutathione (577) 577
hematology (563) 563
toxicity (563) 563
adult (476) 476
middle aged (474) 474
transplantation (464) 464
pharmacology & pharmacy (432) 432
reduced graphene oxide (418) 418
immunology (340) 340
aged (338) 338
rats (333) 333
bone-marrow-transplantation (317) 317
cancer (316) 316
toxicology (310) 310
oxidative stress (309) 309
transplantation conditioning - methods (307) 307
transplantation, homologous (307) 307
treatment outcome (290) 290
research (288) 288
health aspects (285) 285
mice (264) 264
care and treatment (254) 254
chemotherapy (250) 250
glutathione - metabolism (248) 248
glutathione (243) 243
biochemistry & molecular biology (228) 228
hematopoietic stem cells (228) 228
stem cells (227) 227
versus-host-disease (227) 227
adolescent (222) 222
analysis (208) 208
hematopoietic stem cell transplantation - methods (208) 208
risk factors (203) 203
graphene (202) 202
nanoparticles (197) 197
reduced-intensity (194) 194
stem-cell transplantation (189) 189
therapy (176) 176
retrospective studies (173) 173
article (168) 168
chemistry, multidisciplinary (165) 165
reduced folate carrier (163) 163
hematopoietic stem cell transplantation (162) 162
dose-response relationship, drug (160) 160
child (157) 157
young adult (156) 156
materials science, multidisciplinary (155) 155
environmental sciences (153) 153
nanoscience & nanotechnology (153) 153
reduced-intensity conditioning (152) 152
mortality (148) 148
apoptosis (142) 142
physiological aspects (140) 140
methotrexate (138) 138
leukemia (137) 137
time factors (137) 137
in-vitro (131) 131
vidarabine - analogs & derivatives (129) 129
acute myeloid-leukemia (125) 125
hematopoietic stem cell transplantation - adverse effects (125) 125
metabolism (124) 124
disease-free survival (122) 122
cells (118) 118
medicine (118) 118
patient outcomes (118) 118
antioxidants (116) 116
rats, wistar (116) 116
survival analysis (116) 116
cytotoxicity (115) 115
lipid peroxidation (113) 113
antineoplastic combined chemotherapy protocols - therapeutic use (111) 111
enzymes (110) 110
fludarabine (110) 110
lipid-peroxidation (109) 109
transplantation conditioning (107) 107
liver (106) 106
oxidation-reduction (106) 106
oxidative stress - drug effects (103) 103
child, preschool (101) 101
hematologic malignancies (101) 101
review (100) 100
survival (99) 99
acute lymphoblastic-leukemia (98) 98
recurrence (97) 97
survival rate (97) 97
graft vs host disease - prevention & control (95) 95
liver - drug effects (95) 95
prognosis (95) 95
stem cell transplantation (94) 94
chemistry (93) 93
hematology, oncology and palliative medicine (93) 93
reduced intensity conditioning (93) 93
blood (92) 92
children (92) 92
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3243) 3243
Japanese (15) 15
French (14) 14
Polish (4) 4
Spanish (4) 4
Chinese (2) 2
German (2) 2
Korean (2) 2
Arabic (1) 1
Portuguese (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 23, Issue 3, pp. 445 - 451
Journal Article
Cancer, ISSN 0008-543X, 02/2006, Volume 106, Issue 4, pp. 848 - 858
BACKGROUND. Pegylated liposomal doxorubicin has pharmacologic and safety advantages over conventional doxorubicin. METHODS. For this noninteriority trial, 192... 
Dexamethasone | Neutropenic fever | Drug toxicity | Multiple myeloma | Liposomes | Drug resistance | Doxorubicin | Pegylated liposomal doxorubicin | Vincristine | Neoplasms | dexamethasone | 1ST-LINE TREATMENT | multiple myeloma | vincristine | ONCOLOGY-GROUP | liposomes | COMBINATION THERAPY | neutropenic fever | CONVENTIONAL DOXORUBICIN | TRANSPLANTATION | pegylated liposomal doxorubicin | THALIDOMIDE PLUS DEXAMETHASONE | KAPOSIS-SARCOMA | ONCOLOGY | drug toxicity | REDUCED-DOSE DEXAMETHASONE | VAD | doxorubicin | drug resistance | neoplasms | DVD-T | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Polyethylene Glycols - adverse effects | Male | Fever - chemically induced | Multiple Myeloma - drug therapy | Doxorubicin - analogs & derivatives | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Neutropenia - chemically induced | Doxorubicin - administration & dosage | Dexamethasone - administration & dosage | Administration, Oral | Catheterization, Central Venous | Treatment Outcome | Polyethylene Glycols - administration & dosage | Multiple Myeloma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Infusions, Intravenous | Doxorubicin - adverse effects | Pharmaceutical research | Drugs | Myelocytic leukemia | Reports | Nonlymphoid leukemia | Research | Drug therapy, Combination | Drug therapy | Health aspects
Journal Article
BLOOD, ISSN 0006-4971, 05/2007, Volume 109, Issue 10, pp. 4151 - 4157
Treatment-related toxicity in acute lymphoblastic leukemia (ALL) can not only be life threatening but may also affect relapse risk. In 240 patients, we... 
GILBERTS-SYNDROME | BONE-DENSITY | RISK-FACTORS | THERAPY | GENE | REDUCED FOLATE CARRIER | ACUTE LYMPHOBLASTIC-LEUKEMIA | TREATMENT RESPONSE | PHARMACOGENETICS | HEMATOLOGY | CHILDREN
Journal Article
Reviews of environmental contamination and toxicology, ISSN 0179-5953, 2019, Volume 247, pp. 1 - 58
Due to their unique physicochemical properties, graphene-based nanoparticles (GPNs) constitute one of the most promising types of nanomaterials used in... 
Journal Article
Current Opinion in Cardiology, ISSN 0268-4705, 05/2019, Volume 34, Issue 3, pp. 283 - 288
PURPOSE OF REVIEWThe purpose of this review is to discuss the clinical and treatment-related factors that increase the risk of cardiotoxicity with... 
ADJUVANT CHEMOTHERAPY | risk factors | CARDIAC & CARDIOVASCULAR SYSTEMS | TRASTUZUMAB | LIPOSOME-ENCAPSULATED DOXORUBICIN | REDUCED CARDIOTOXICITY | RANDOMIZED-TRIAL | FOLLOW-UP | CONVENTIONAL DOXORUBICIN | chemotherapy | MULTICENTER TRIAL | cardiotoxicity | BREAST-CANCER PATIENTS | cancer | CONGESTIVE-HEART-FAILURE
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 10/2011, Volume 67, Issue 10, pp. 993 - 1006
The objectives of this study were (1) to develop a population pharmacokinetic model of high-dose methotrexate (HD-MTX) in children with acute lymphoblastic... 
Population pharmacokinetics | Pharmacogenetics | Biomedicine | Toxicity | Acute lymphoblastic leukaemia | Children | Pharmacology/Toxicology | Methotrexate | THYMIDYLATE SYNTHASE | HIGH-DOSE METHOTREXATE | CARRIER GENE | RHEUMATOID-ARTHRITIS PATIENTS | METHYLENETETRAHYDROFOLATE REDUCTASE | BREAST-CANCER | METHIONINE SYNTHASE REDUCTASE | BFM 90 | PHARMACOLOGY & PHARMACY | PLASMA HOMOCYSTEINE | Antimetabolites, Antineoplastic - pharmacokinetics | Humans | Methotrexate - pharmacokinetics | Child, Preschool | Male | Lymphoma - metabolism | Thrombocytopenia - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Lymphoma - drug therapy | Methylenetetrahydrofolate Reductase (NADPH2) - genetics | Female | Retrospective Studies | Odds Ratio | Lymphoma - genetics | Reduced Folate Carrier Protein - genetics | Genotype | Methotrexate - blood | Polymorphism, Genetic | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Methotrexate - adverse effects | Metabolic Networks and Pathways | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | Antimetabolites, Antineoplastic - adverse effects | Folic Acid - metabolism | ATP Binding Cassette Transporter, Sub-Family B | Mucositis - genetics | Folic Acid - genetics | Nonlinear Dynamics | Analysis | Genetic research | Lymphomas | Genetic aspects | Dosage and administration | Universities and colleges | Folic acid | Leukemia | Genetics | Pharmacology | Drug therapy | Children & youth | Index Medicus
Journal Article
Science of the Total Environment, ISSN 0048-9697, 02/2017, Volume 580, pp. 1300 - 1308
Journal Article
Molecular Pharmaceutics, ISSN 1543-8384, 12/2010, Volume 7, Issue 6, pp. 1948 - 1958
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 01/2018, Volume 65, Issue 1, pp. e26783 - n/a
Journal Article